蒙古国病毒性肝炎与肝脏疾病的流行病学
Epidemiology of Viral Hepatitis and Liver Diseases in Mongolia.
作者信息
Tsatsralt Od Bira
机构信息
Department of Gastroenterology, National Institute of Medicine, Ministry of Health, Education and Science, Ulaanbaatar, Mongolia.
出版信息
Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):37-39. doi: 10.5005/jp-journals-10018-1127. Epub 2015 Jan 6.
UNLABELLED
Mongolia which is located in Northern Asia between Russia and China is endowed with one of lowest population density in the world. Acute hepatitis due all types of hepatitis virus has been reported in Mongolia. Also, dual and triple hepatitis viruses, HBV, HDV and HCV are highly prevalent among patients with chronic liver disease living in Mongolia. Due to these facts, liver cancer is the leading cause of cancer mortality in Mongolia. The national immunization program including vaccination against hepatitis B was started in 1991 and screening of blood donations for HBsAg and anti-HCV was introduced in 1993 and 1997 respectively. The incidence of hepatitis viruses showing a downhill course in some parts of Mongolia, but comprehensive efforts are needed to control hepatitis viruses and containment of hepatitis related liver diseases and liver cancer in Mongolia.
HOW TO CITE THIS ARTICLE
Tsatsralt OB. Epidemiology of Viral Hepatitis and Liver Diseases in Mongolia. Euroasian J Hepato-Gastroenterol 2015;5(1):37-39.
未标注
蒙古国位于亚洲北部，介于俄罗斯和中国之间，是世界上人口密度最低的国家之一。蒙古国已报告了由各类肝炎病毒引起的急性肝炎。此外，乙型肝炎病毒（HBV）、丁型肝炎病毒（HDV）和丙型肝炎病毒（HCV）等双重和三重肝炎病毒在蒙古国慢性肝病患者中高度流行。鉴于这些情况，肝癌是蒙古国癌症死亡的主要原因。包括乙肝疫苗接种在内的国家免疫规划于1991年启动，分别于1993年和1997年开始对献血者进行乙肝表面抗原（HBsAg）和抗丙肝病毒（anti-HCV）筛查。蒙古国部分地区肝炎病毒的发病率呈下降趋势，但仍需要做出全面努力来控制肝炎病毒，并遏制蒙古国与肝炎相关的肝脏疾病和肝癌。
如何引用本文
察斯拉尔特·奥布。蒙古国病毒性肝炎和肝脏疾病的流行病学。《欧亚肝脏病与胃肠病学杂志》2015年；5(1):37 - 39。
Zotero 插件